Greater access to life-changing medicine for Australians with ADHD
Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS). Federal Member for Page Kevin Hogan said from today the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are…